Sutro Biopharma
STRO
STRO
120 hedge funds and large institutions have $252M invested in Sutro Biopharma in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $248M → $252M (+$4.09M)
3.52% less ownership
Funds ownership: 93.07% → 89.55% (-3.5%)
Holders
120
Holding in Top 10
–
Calls
$27K
Puts
$5K
Top Buyers
| 1 | +$4.58M | |
| 2 | +$3.72M | |
| 3 | +$3.48M | |
| 4 |
Millennium Management
New York
|
+$2.85M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$2.78M |
Top Sellers
| 1 | -$8.5M | |
| 2 | -$4.63M | |
| 3 | -$1.87M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.45M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$1.45M |